Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
The increasing prevalence of heart failure (HF) serves as a reverse side of the effective treatment for cardiovascular diseases (CVD) and increasing patient survival. Data on the epidemiology of HF and related mortality in Russia are limited. According to the EPOCHA trial (hospital phase), the preva...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2020-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849249832349204480 |
|---|---|
| author | E. V. Shlyakhto N. E. Zvartau S. V. Villevalde A. N. Yakovlev A. E. Soloveva A. A. Fedorenko V. A. Karlina N. G. Avdonina G. V. Endubaeva V. V. Zaitsev G. A. Neplyueva E. I. Pavlyuk M. V. Dubinina E. A. Medvedeva A. M. Erastov S. A. Panarina A. E. Solovev |
| author_facet | E. V. Shlyakhto N. E. Zvartau S. V. Villevalde A. N. Yakovlev A. E. Soloveva A. A. Fedorenko V. A. Karlina N. G. Avdonina G. V. Endubaeva V. V. Zaitsev G. A. Neplyueva E. I. Pavlyuk M. V. Dubinina E. A. Medvedeva A. M. Erastov S. A. Panarina A. E. Solovev |
| author_sort | E. V. Shlyakhto |
| collection | DOAJ |
| description | The increasing prevalence of heart failure (HF) serves as a reverse side of the effective treatment for cardiovascular diseases (CVD) and increasing patient survival. Data on the epidemiology of HF and related mortality in Russia are limited. According to the EPOCHA trial (hospital phase), the prevalence of HF in the Russian Federation is 7%. HF can significantly contribute to cardiovascular mortality. However, its recognition is limited by the peculiarities of the mortality coding system in Russia. The article presents the authors’ view on the registration of HF-related morbidity and mortality cases and perspectives of using left ventricular ejection fraction <50% for statistical reporting. |
| format | Article |
| id | doaj-art-7572b36ce2eb4cc8bcd22aa4a42d7ed5 |
| institution | Kabale University |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2020-12-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-7572b36ce2eb4cc8bcd22aa4a42d7ed52025-08-20T03:57:26Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202020-12-01251210.15829/1560-4071-2020-42043109Assessment of prevalence and monitoring of outcomes in patients with heart failure in RussiaE. V. Shlyakhto0N. E. Zvartau1S. V. Villevalde2A. N. Yakovlev3A. E. Soloveva4A. A. Fedorenko5V. A. Karlina6N. G. Avdonina7G. V. Endubaeva8V. V. Zaitsev9G. A. Neplyueva10E. I. Pavlyuk11M. V. Dubinina12E. A. Medvedeva13A. M. Erastov14S. A. Panarina15A. E. Solovev16Almazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterThe increasing prevalence of heart failure (HF) serves as a reverse side of the effective treatment for cardiovascular diseases (CVD) and increasing patient survival. Data on the epidemiology of HF and related mortality in Russia are limited. According to the EPOCHA trial (hospital phase), the prevalence of HF in the Russian Federation is 7%. HF can significantly contribute to cardiovascular mortality. However, its recognition is limited by the peculiarities of the mortality coding system in Russia. The article presents the authors’ view on the registration of HF-related morbidity and mortality cases and perspectives of using left ventricular ejection fraction <50% for statistical reporting.https://russjcardiol.elpub.ru/jour/article/view/4204heart failureprevalencemorbiditymortalityleft ventricular ejection fraction |
| spellingShingle | E. V. Shlyakhto N. E. Zvartau S. V. Villevalde A. N. Yakovlev A. E. Soloveva A. A. Fedorenko V. A. Karlina N. G. Avdonina G. V. Endubaeva V. V. Zaitsev G. A. Neplyueva E. I. Pavlyuk M. V. Dubinina E. A. Medvedeva A. M. Erastov S. A. Panarina A. E. Solovev Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia Российский кардиологический журнал heart failure prevalence morbidity mortality left ventricular ejection fraction |
| title | Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia |
| title_full | Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia |
| title_fullStr | Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia |
| title_full_unstemmed | Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia |
| title_short | Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia |
| title_sort | assessment of prevalence and monitoring of outcomes in patients with heart failure in russia |
| topic | heart failure prevalence morbidity mortality left ventricular ejection fraction |
| url | https://russjcardiol.elpub.ru/jour/article/view/4204 |
| work_keys_str_mv | AT evshlyakhto assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT nezvartau assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT svvillevalde assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT anyakovlev assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT aesoloveva assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT aafedorenko assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT vakarlina assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT ngavdonina assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT gvendubaeva assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT vvzaitsev assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT ganeplyueva assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT eipavlyuk assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT mvdubinina assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT eamedvedeva assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT amerastov assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT sapanarina assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia AT aesolovev assessmentofprevalenceandmonitoringofoutcomesinpatientswithheartfailureinrussia |